-
Major discoveries! Shale oil reserves in Taizhou City, Jiangsu Province, amounted to 350 million tons
Time of Update: 2023-03-19
According to the preliminary evaluation, Sinopec has implemented a favorable area of 420 square kilometers and 350 million tons of shale oil resources in the Qintong Sag area of the Northern Jiangsu Basin, which demonstrates the good prospects for exploration and development in the region and will open up a strategic succession position for crude oil resources in China's Northern Jiangsu Basin.
-
Repsol made a profit of 2.5 billion euros last year
Time of Update: 2023-03-10
4 billion) in revenue during the year, including €624 million (£521 million) in the fourth quarter.
4 billion) in revenue during the year, including €624 million (£521 million) in the fourth quarter.
4 billion) in revenue during the year, including €624 million (£521 million) in the fourth quarter.
-
Progress in Eastern Europe intensifies energy supply concerns Crude oil closed sharply higher, and oil hit a new high in more than seven years
Time of Update: 2023-03-09
News on February 23, the tension between Russia and Ukraine has risen, intensifying concerns about the outlook for energy supply, crude oil futures and natural gas prices have risen sharply, and Brent crude oil has reached the highest level since 2014.
-
my country's sulfuric acid production hits record high in 2021
Time of Update: 2023-02-12
5% over 2020 The "Report" shows that in 2021, China's total sulfuric acid production capacity will reach 128 million tons, an increase of 0.
5% over 2020 The "Report" shows that in 2021, China's total sulfuric acid production capacity will reach 128 million tons, an increase of 0.
-
In June, my country imported 18.982 million tons of coal, a year-on-year decrease of 33.14
Time of Update: 2023-02-10
Data released by the General Administration of Customs shows that in June 2022, China imported 18.
549 million tons in May % Data released by the General Administration of Customs shows that in June 2022, China imported 18.
-
For $1.235 billion, PeptiDream partnered with Eli Lilly to develop PDC drugs
Time of Update: 2023-02-03
PeptiDream's R&D pipeline Original English text: _mstmutation="1" _msthash="220728" _msttexthash="2926391"> December 26 Japanese biotech company PeptiDream announced that it has entered into a joint research and licensing agreement with Eli Lilly for the creation and development of innovative peptide drug conjugates (PDCs).
-
Vietnam's seafood exports are expected to reach US$11 billion this year
Time of Update: 2023-02-02
Vietnam is a major producer of farmed shrimp and pangasius on December 23, and seafood export revenue is expected to reach a record US$11 billion this year, up 25% from 2021.
-
Using Jinhua furnace 3.0, the two projects were successfully ignited one after another
Time of Update: 2023-02-01
Previously, after the gasifier B furnace of Zhejiang Jinju project was commissioned, it was successfully ignited at 5:48 on January 1.
Previously, after the gasifier B furnace of Zhejiang Jinju project was commissioned, it was successfully ignited at 5:48 on January 1.
-
10 trillion won
Time of Update: 2023-01-10
7 billion) by 2025 to accelerate "sustainable growth" in its battery materials business and other business lines South Korea's LG Chem recently said it plans to invest 10 trillion won ($8.
-
Renewables accounted for 98.6% of Scotland's total electricity consumption in 2020
Time of Update: 2023-01-06
Scotland has missed its target of generating 100% of its electricity demand from renewable sources by 2020.
Scotland has missed its target of generating 100% of its electricity demand from renewable sources by 2020.
-
One injection is effective for a long time, and the clinical data of the Nobel Prize team's second in vivo CRISPR therapy was released
Time of Update: 2023-01-06
On June 24, 2022, Intellia announced interim data from the latest Phase 1 clinical trial of NTLA-2001 therapy, which was positive, and the decline in TTR protein levels in the serum after a single dose was stable and sustained for up to 12 months 。 The main results were as follows: 1.
-
One injection is effective for a long time, and the clinical data of the Nobel Prize team's second in vivo CRISPR therapy was released
Time of Update: 2023-01-06
On June 24, 2022, Intellia announced interim data from the latest Phase 1 clinical trial of NTLA-2001 therapy, which was positive, and the decline in TTR protein levels in the serum after a single dose was stable and sustained for up to 12 months 。 The main results were as follows: 1.
-
Highlight the encirclement! T-DXd that ushered in a new era of ADCs
Time of Update: 2023-01-06
But now T-DXd has changed that result, and studies have found that T-Dxd in breast cancer patients with "low HER2 expression" is significantly better than the current standard of care: chemotherapy.
-
Highlight the encirclement! T-DXd that ushered in a new era of ADCs
Time of Update: 2023-01-06
But now T-DXd has changed that result, and studies have found that T-Dxd in breast cancer patients with "low HER2 expression" is significantly better than the current standard of care: chemotherapy.
-
First-line treatment prolongs the lives of gastric cancer patients, and the potential "first-in-class" therapy has been clinically validated for the first time in Phase 3
Time of Update: 2023-01-06
Looking forward to the new year, in order to have a more comprehensive understanding of the views and insights of friends in the biomedical industry on the development of the industry, we invite you to spend 1 minute in your busy schedule to fill out this questionnaire (long press to scan the code, or▎WuXi AppTec content team editor On November 17, Astellas Pharma announced that zolbetuximab, an investigational antibody therapy targeting Claudin18.
